Suvoda has introduced new split budget functionality to its clinical trial software, Budgeting & Benchmarking, supporting sponsors and contract research organisations (CROs) in managing complex, multi-payee site budgets across worldwide studies.
Previously known as EnvisiX, Budgeting & Benchmarking is Suvoda’s platform for structuring clinical trial site budgets utilising real-time fair market value data.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Sponsors and CROs can use the platform to develop accurate budgets while removing manual spreadsheets and email correspondence through a controlled and auditable workflow linked directly to downstream site payments.
In several regions, establishing a clinical trial budget requires more than a single agreement between sponsors and sites.
Suvoda stated that multiple entities at one site, including laboratories or affiliated institutions, radiology departments, investigators, often necessitate separate contracts and payments. Previously, sponsors managed these processes outside their budgeting tools, resulting in compliance risks, inefficiencies and delays.
With the new split budget functionality, sponsors can now manage multi-payee scenarios directly within the Budgeting & Benchmarking solution, catering to the diverse site operating models seen worldwide without leaving the system.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThis enhancement allows sponsors to configure budget structures reflecting different payees within one site and negotiate costs individually for investigators, departments, and external facilities.
It enables maintenance of a single structured workflow for all countries and sites in a trial, avoids the use of offline tools for complex scenarios, and prepares budgets that connect seamlessly to downstream payment configurations.
The latest release is the first in a series of planned enhancements to Greenphire Clinical Finance, Budgeting & Benchmarking, aiming to create scalable solutions from study feasibility through final site payment.
Suvoda senior product manager Iain Wood said: “Investigator grant budgeting is not just an administrative step in a clinical trial. It is foundational to the sponsor-site relationship and whether payments can be executed accurately and efficiently later.
“When budgeting processes require manual workarounds, it can impact clinical trial timelines, quality, and ultimately how quickly sites can begin enrolling patients.”
